Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Scientists reveal how DNA damage leads to cancer and hereditary diseases

Scientists reveal how DNA damage leads to cancer and hereditary diseases

Merck declares 2018 Life Science Award winners

Merck declares 2018 Life Science Award winners

Towards finding a druggable cancer target

Towards finding a druggable cancer target

New report highlights key focus areas to help cancer screening realize its full potential

New report highlights key focus areas to help cancer screening realize its full potential

Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway

Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway

Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis

Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Circadian clock could play key role in the fight against liver cancer

Circadian clock could play key role in the fight against liver cancer

Study could provide novel treatment strategy for potentially blinding problem

Study could provide novel treatment strategy for potentially blinding problem

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Study offers hope of early detection, treatment of liver cancer

Study offers hope of early detection, treatment of liver cancer

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

Researchers identify new potential target to inhibit progression of liver disease

Researchers identify new potential target to inhibit progression of liver disease

New partnership aims to tackle cancer health disparities

New partnership aims to tackle cancer health disparities

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Study finds link between refined soluble fibers, gut microbiota and liver cancer

Study finds link between refined soluble fibers, gut microbiota and liver cancer

Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer

Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer

One-time universal screening recommended to tackle increase in hepatitis C

One-time universal screening recommended to tackle increase in hepatitis C

Researchers use CRISPR-Cas9 to prevent congenital disease in utero

Researchers use CRISPR-Cas9 to prevent congenital disease in utero